BackAcelrx Pharmaceuticals Overview

Acelrx Pharmaceuticals Operating Income

Operating Income for ACRX.

Quarterly Operating Income

$-3948000.00
35.39% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-14516000.00
23.97% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)